Funding
The trial is funded by:
- Aarhus University Research Foundation (kr. 3,000,000)
- Department of Clinical Medicine, Aarhus University (kr. 950,000)
- Independent Research Fund Denmark (kr. 2,343,000)
- Health Research Foundation of Central Denmark Region (kr. 55,751)
- Vasopressin is provided free of charge by Amomed Pharma GmbH
The funding agencies and Amomed Pharma GmbH have no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of any manuscripts; or the decision to submit any manuscripts for publication.